Incidence of brain metastases after first line chemotherapy in breast cancer patients treated with or without trastuzumab.

Abstract

10582 Background: Brain metastases during trastuzumab therapy have been frequently observed. Only a few studies have compared the risk of brain metastases in patients (pts) treated with or without trastuzumab. METHODS In our hospital, between Jun 2000 and September 2005, we conducted a retrospective study in 72 metastatic breast cancer pts treated with… (More)

Topics

Cite this paper

@article{Ferretti2006IncidenceOB, title={Incidence of brain metastases after first line chemotherapy in breast cancer patients treated with or without trastuzumab.}, author={Gianluigi Ferretti and Alessandra Felici and Maria Simona Pino and Paolo Carlini and Alessandra Fabi and Carmen M. A. Nuzzo and Isabella Sperduti and Francesco Cognetti and Paola Papaldo}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2006}, volume={24 18_suppl}, pages={10582} }